Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$5.8M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$131M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Ragan Paula | Oct 15, 2024 | Sell | 31,897 | $0.562 | $18,000 |
| Mostafa Adam S. | Oct 7, 2024 | Sell | 230,645 | $0.5502 | $130,000 |
| Ragan Paula | Oct 7, 2024 | Sell | 239,436 | $0.5493 | $130,000 |
| Baldry Mark | Oct 7, 2024 | Sell | 11,127 | $0.5847 | $6,500 |
| DiBiase Mary | Oct 7, 2024 | Sell | 67,695 | $0.5662 | $38,000 |
| Taveras Arthur | Oct 7, 2024 | Sell | 76,920 | $0.563 | $43,000 |
| DiBiase Mary | Sep 9, 2024 | Sell | 2,642 | $0.6577 | $1,700 |
| Taveras Arthur | Mar 11, 2024 | Sell | 14,235 | $0.8818 | $13,000 |
| Ragan Paula | Mar 11, 2024 | Sell | 49,678 | $0.8828 | $44,000 |
| Mostafa Adam S. | Mar 11, 2024 | Sell | 52,500 | $0.8828 | $46,000 |
| DiBiase Mary | Mar 11, 2024 | Sell | 15,409 | $0.882 | $14,000 |
| Ragan Paula | Nov 3, 2023 | Sell | 39,906 | $0.9 | $36,000 |
| Ragan Paula | Nov 1, 2023 | Sell | 199,531 | $0.73 | $150,000 |
| Mostafa Adam S. | Nov 1, 2023 | Sell | 230,645 | $0.73 | $170,000 |
| DiBiase Mary | Nov 1, 2023 | Sell | 67,695 | $0.73 | $49,000 |
| Baldry Mark | Nov 1, 2023 | Sell | 10,257 | $0.73 | $7,500 |
| Taveras Arthur | Nov 1, 2023 | Sell | 67,695 | $0.73 | $49,000 |
| DiBiase Mary | Sep 8, 2023 | Sell | 2,642 | $1.249 | $3,300 |
| WYZGA MICHAEL S | Aug 18, 2023 | Buy | 25,000 | $1.195 | $30,000 |
| Stewart Murray | Aug 10, 2023 | Sell | 130,056 | $1.06 | $140,000 |
| Mostafa Adam S. | Jun 30, 2023 | Sell | 2,641 | $1.89 | $5,000 |
| DiBiase Mary | Jun 30, 2023 | Sell | 464 | $1.89 | $880 |
| Ragan Paula | Jun 23, 2023 | Sell | 6,724 | $1.92 | $13,000 |
| Mostafa Adam S. | Jun 15, 2023 | Sell | 5,417 | $2.22 | $12,000 |
| Ragan Paula | Jun 15, 2023 | Sell | 6,724 | $2.23 | $15,000 |
| DiBiase Mary | Jun 15, 2023 | Sell | 857 | $2.23 | $1,900 |
| Ragan Paula | May 31, 2023 | Sell | 6,292 | $1.95 | $12,000 |
| DiBiase Mary | Mar 10, 2023 | Sell | 18,192 | $0.84 | $15,000 |
| Mostafa Adam S. | Mar 10, 2023 | Sell | 52,500 | $0.84 | $44,000 |
| Taveras Arthur | Mar 10, 2023 | Sell | 16,806 | $0.84 | $14,000 |
| Ragan Paula | Mar 10, 2023 | Sell | 49,678 | $0.84 | $42,000 |
| Mostafa Adam S. | Feb 13, 2023 | Sell | 27,721 | $0.93 | $26,000 |
| Ragan Paula | Feb 13, 2023 | Sell | 21,695 | $0.93 | $20,000 |
| DiBiase Mary | Feb 13, 2023 | Sell | 4,348 | $0.93 | $4,000 |
| Taveras Arthur | Feb 13, 2023 | Sell | 928 | $0.93 | $860 |
What's the latest insider transaction for X4 Pharmaceuticals?
The most recent insider transaction for X4 Pharmaceuticals was conducted by Ragan Paula, who sold 31,897 shares on October 15, 2024 at a price of $0.56 per share.
Which insider bought the most XFOR stock over the last two years?
WYZGA MICHAEL S has bought the most XFOR stock in the last 2 years, with a total value of $30,000.
Which insider has sold the most XFOR stock over the last two years?
Ragan Paula has sold the most XFOR stock in the last 2 years, with a total value of $480,000.
What is the total value of insider transactions for X4 Pharmaceuticals (XFOR) in the last 2 years?
The total value of insider transactions for X4 Pharmaceuticals in the last 2 years is negative, amounting to -$1.3M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on X4 Pharmaceuticals' market confidence?
Over the last 2 years, insider transactions for X4 Pharmaceuticals have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
